NO942396L - Preparat med vedvarende frigiving av anti-endotelin substans - Google Patents
Preparat med vedvarende frigiving av anti-endotelin substansInfo
- Publication number
- NO942396L NO942396L NO942396A NO942396A NO942396L NO 942396 L NO942396 L NO 942396L NO 942396 A NO942396 A NO 942396A NO 942396 A NO942396 A NO 942396A NO 942396 L NO942396 L NO 942396L
- Authority
- NO
- Norway
- Prior art keywords
- endothelin
- substance
- continuous release
- endothelin substance
- sustained
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15339393 | 1993-06-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942396D0 NO942396D0 (cs) | 1994-06-23 |
| NO942396L true NO942396L (no) | 1994-12-27 |
Family
ID=15561515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942396A NO942396L (no) | 1993-06-24 | 1994-06-23 | Preparat med vedvarende frigiving av anti-endotelin substans |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0647449A1 (cs) |
| KR (1) | KR950000167A (cs) |
| CN (1) | CN1109780A (cs) |
| CA (1) | CA2126619A1 (cs) |
| FI (1) | FI943071L (cs) |
| NO (1) | NO942396L (cs) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6087324A (en) | 1993-06-24 | 2000-07-11 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| CN1157562A (zh) * | 1994-09-09 | 1997-08-20 | 武田药品工业株式会社 | 含有一种肽金属盐的缓释制剂 |
| US5573762A (en) * | 1995-04-24 | 1996-11-12 | Genentech, Inc. | Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy |
| US6251861B1 (en) | 1996-06-27 | 2001-06-26 | Takeda Chemical Industries, Ltd. | Treatment of cerebral infarction using cyclic hexapeptides |
| US5985830A (en) * | 1996-09-16 | 1999-11-16 | Dalhousie University | Use of IGF-I for the treatment of kidney disorders |
| CA2348292A1 (en) * | 1998-10-30 | 2000-05-11 | Takeda Chemical Industries, Ltd. | Betacellulin protein-containing preparation |
| AUPP785098A0 (en) | 1998-12-21 | 1999-01-21 | Victor Chang Cardiac Research Institute, The | Treatment of heart disease |
| US6635249B1 (en) | 1999-04-23 | 2003-10-21 | Cenes Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
| KR100522277B1 (ko) * | 2000-04-28 | 2005-10-18 | 다나베 세이야꾸 가부시키가이샤 | 미소구체 제조 방법 |
| WO2003099320A1 (en) | 2002-05-24 | 2003-12-04 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
| JP2004331750A (ja) | 2003-05-02 | 2004-11-25 | Canon Inc | ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途 |
| US20070213264A1 (en) | 2005-12-02 | 2007-09-13 | Mingdong Zhou | Neuregulin variants and methods of screening and using thereof |
| WO2007076701A1 (en) | 2005-12-30 | 2007-07-12 | Zensun (Shanghai) Science & Technology Limited | Extended release of neuregulin for improved cardiac function |
| WO2009026517A2 (en) | 2007-08-22 | 2009-02-26 | Gilead Colorado, Inc. | Therapy for complications of diabetes |
| US20090156488A1 (en) | 2007-09-12 | 2009-06-18 | Zensun (Shanghai) Science & Technology Limited | Use of neuregulin for organ preservation |
| WO2013053076A1 (en) | 2011-10-10 | 2013-04-18 | Zensun （Shanghai）Science & Technology Limited | Compositions and methods for treating heart failure |
| BR112015029293A2 (pt) | 2013-05-22 | 2018-04-24 | Zensun Shanghai Science & Tech Ltd | método e kit para prevenir, tratar ou retardar uma doença ou distúrbio cardiovascular em um mamífero |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69220861T2 (de) * | 1991-08-13 | 1997-11-20 | Takeda Chemical Industries Ltd | Zyklische Peptide und ihre Verwendung |
| TW333456B (en) * | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
-
1994
- 1994-06-23 EP EP94304566A patent/EP0647449A1/en not_active Withdrawn
- 1994-06-23 CA CA002126619A patent/CA2126619A1/en not_active Abandoned
- 1994-06-23 FI FI943071A patent/FI943071L/fi not_active Application Discontinuation
- 1994-06-23 KR KR1019940014507A patent/KR950000167A/ko not_active Withdrawn
- 1994-06-23 NO NO942396A patent/NO942396L/no unknown
- 1994-06-24 CN CN94115973A patent/CN1109780A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI943071A0 (fi) | 1994-06-23 |
| FI943071A7 (fi) | 1994-12-25 |
| EP0647449A1 (en) | 1995-04-12 |
| CA2126619A1 (en) | 1994-12-25 |
| FI943071L (fi) | 1994-12-25 |
| KR950000167A (ko) | 1995-01-03 |
| CN1109780A (zh) | 1995-10-11 |
| NO942396D0 (cs) | 1994-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO942396L (no) | Preparat med vedvarende frigiving av anti-endotelin substans | |
| NO962088D0 (no) | Preparat for in vivo-produksjon av terapeutiske produkter | |
| ATE417604T1 (de) | Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe | |
| IS4146A (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
| FI951379A0 (fi) | Biohajoavista kopolymeereistä koostuvia mikrohiukkasvalmisteita | |
| FI972963A7 (fi) | Biohajoavia polymeerejä, menetelmiä niiden valmistamiseksi ja niiden käyttö biohajoavien muovaustuotteiden valmistamiseen | |
| FI972964A7 (fi) | Biohajoavia polymeereja, menetelmiä niiden valmistamiseksi ja niiden käyttö biohajoavien muovaustuotteiden valmistamiseen | |
| AU2003297260A1 (en) | Fast-disintegrating solid dosage forms being not friable and comprising pullulan | |
| NO307968B1 (no) | Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav | |
| PT839525E (pt) | Preparacao de libertacao prolongada | |
| MY107500A (en) | Preparation process of sustained release compositions and the compositions thus obtained | |
| PT841903E (pt) | Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida | |
| DE59608732D1 (de) | Lagerstabile arzneiformen | |
| ATE232396T1 (de) | Oxydiertes thymosin beta 4 | |
| TR199801579T2 (xx) | Polimerlere dayanan b�cek �ld�r�c� bile�imler. | |
| DK0770384T3 (da) | Faste, vandfrie farmaceutiske sammensætninger til vaginal anvendelse | |
| NO994165D0 (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| TR28109A (tr) | Duman halinde dezenfekte eden formülasyonlar. | |
| DE69941825D1 (de) | Arzneistoffhaltiger kaugummi, dessen herstellungsverfahren und so erhaltene tablette | |
| NO980296L (no) | Forbedrede terapeutiske midler | |
| IS5366A (is) | Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi | |
| EP0859597A4 (cs) | ||
| SE0001916D0 (sv) | Novel formulation | |
| ATE236621T1 (de) | Niedrig dosierte tabletten, und verfahren zur herstellung | |
| DE59101818D1 (de) | Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung. |